Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Mertelsmann, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 223 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mertelsmann, R
      Plasticity of bone marrow-derived stem cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Fetscher, S; Mertelsmann, R
      Supportive care in hematologic malignancies: hematopoietic growth factors,infections, transfusion therapy

      CURRENT OPINION IN HEMATOLOGY
    3. Lazzari, L; Henschler, R; Lecchi, L; Rebulla, P; Mertelsmann, R; Sirchia, G
      Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41(+) and CD61(+) megakaryocytic cells

      HAEMATOLOGICA
    4. Mackensen, A; Drager, R; Schlesier, M; Mertelsmann, R; Lindemann, A
      Presence of IgE antibodies to bovine serum albumin in a patient developinganaphylaxis after vaccination with human peptide-pulsed dendritic cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    5. Finke, J; Bertz, H; Schmoor, C; Veelken, H; Behringer, D; Wasch, R; Kunzmann, R; Heidecker, L; Lang, H; Meyer-Konig, U; Mertelsmann, R
      Allogeneic bone marrow transplantation from unrelated donors using in vivoanti-T-cell globulin

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Herrmann, F; Bambach, T; Bonifer, R; Lindemann, A; Riedel, D; Oster, W; Mertelsmann, R
      The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: Synergism with interferon-gamma (retraction from the International Journal of Cell Cloning, vol 6, pg 241-261, 1988)

      STEM CELLS
    7. Schreiber, S; Kampgen, E; Wagner, E; Pirkhammer, D; Trcka, J; Korschan, H; Lindemann, A; Dorffner, R; Kittler, H; Kasteliz, F; Kupcu, Z; Sinski, A; Zatloukal, K; Buschle, M; Schmidt, W; Birnstiel, M; Kempe, RE; Voigt, T; Weber, HA; Pehamberger, H; Mertelsmann, R; Brocker, EB; Wolff, K; Stingl, G
      Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2 transfected cancer cells: Outcome of a phase I study

      HUMAN GENE THERAPY
    8. Fetscher, S; Brugger, W; Engelhardt, R; Kanz, L; Hasse, J; Frommhold, H; Lange, W; Mertelsmann, R
      Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicinin 100 patients with small-cell lung cancer: A mature follow-up report

      ANNALS OF ONCOLOGY
    9. Fetscher, S; Brugger, W; Engelhardt, R; Kanz, L; Hasse, J; Frommhold, H; Lange, W; Mertelsmann, R
      Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicinin 107 patients with non-small-cell lung cancer: A mature follow-up report

      ANNALS OF ONCOLOGY
    10. Mackensen, A; Krause, T; Blum, U; Uhrmeister, P; Mertelsmann, R; Lindemann, A
      Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    11. Berger, C; Bertz, H; Schmoor, C; Behringer, D; Potthoff, K; Mertelsmann, R; Finke, J
      Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors

      BONE MARROW TRANSPLANTATION
    12. Wurthner, JU; Kohler, G; Behringer, D; Lindemann, A; Mertelsmann, R; Lubbert, M
      Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis - A clinicopathologic report of four cases

      CANCER
    13. Oster, W; Brach, MA; Gruss, HJ; Mertelsmann, R; Herrmann, F
      Interleukin-1 beta (IL-1 beta) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF and IL-3 (Retraction of vol 79, pg 1260, 1992)

      BLOOD
    14. Hermann, F; Andreeff, M; Gruss, HJ; Brach, MA; Lubbert, M; Mertelsmann, R
      Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression (Retraction of vol 78, pg 2070, 1991)

      BLOOD
    15. Veelken, H; Mertelsmann, R
      Gene therapy and molecular manipulation

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    16. GLIMM H; FLUGGE K; MOBEST D; HOFMANN VM; POSTMUS J; HENSCHLER R; LANGE W; FINKE J; KIEM HP; SCHULZ G; ROSENTHAL F; MERTELSMANN R; VONKALLE C
      EFFICIENT SERUM-FREE RETROVIRAL GENE-TRANSFER INTO PRIMITIVE HUMAN HEMATOPOIETIC PROGENITOR CELLS BY A DEFINED, HIGH-TITER, NONCONCENTRATEDVECTOR-CONTAINING MEDIUM

      Human gene therapy
    17. WEBERNORDT RM; MERTELSMANN R; FINKE J
      THE JAK-STAT PATHWAY - SIGNAL-TRANSDUCTION INVOLVED IN PROLIFERATION,DIFFERENTIATION AND TRANSFORMATION

      Leukemia & lymphoma
    18. ZENZ T; MERTELSMANN R; ZENZ M
      STATUS OF CANCER PAIN MANAGEMENT IN GERMANY - AN INPATIENT AND OUTPATIENT PERSPECTIVE

      European journal of cancer
    19. SPYRIDONIDIS A; BERNHARDT W; FETSCHER S; BEHRINGER D; MERTELSMANN R; HENSCHLER R
      MINIMAL RESIDUAL DISEASE IN AUTOLOGOUS HEMATOPOIETIC HARVESTS FROM BREAST-CANCER PATIENTS

      Annals of oncology
    20. BRACH MA; MERTELSMANN R; HERRMANN F
      MODULATION OF CYTOTOXICITY AND DIFFERENTIATION-INDUCING POTENTIAL OF ARABINOFURANOSYLCYTOSINE IN MYELOID-LEUKEMIA CELLS BY HEMATOPOIETIC CYTOKINES (VOL 11, PG 198, 1993)

      Cancer investigation
    21. FINKE J; BERTZ H; AFTING M; BEHRINGER D; BERGER C; HEIDECKER L; KUNZMANN R; MARKS R; POTTHOFF K; WASCH R; WINKLER J; MERTELSMANN R
      ALLOGENEIC TRANSPLANTATION OF CD34-BLOOD PROGENITOR CELLS( SELECTED OR UNSELECTED PERIPHERAL)

      Bone marrow transplantation
    22. PASSWEG J; FASSAS A; FURST D; BLACK C; FINKE J; JOUET J; LOCATELLI F; MARMONT A; MARTINI A; MERTELSMANN R; MUSSO M; PETER H; PRENTICE H; SULLIVAN K; GRATWOHL A; TYNDALL A
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASE - A PRELIMINARY-REPORT

      Bone marrow transplantation
    23. BERTZ H; EISOLD A; HEIDECKER L; LEIFERT J; MERTELSMANN R; FINKE J
      POSTTRANSPLANT MICROANGIOPATHIC HEMOLYTIC-ANEMIA (MAHA) IS ASSOCIATEDWITH ACUTE GVHD

      Bone marrow transplantation
    24. BERTZ H; SCHMOLK J; KORTSIK P; HEIDECKER L; LEIFERT J; MERTELSMANN R; FINKE J
      SEQUENTIAL PULMONARY-FUNCTION TESTING AFTER ALLOGENEIC TRANSPLANTATION

      Bone marrow transplantation
    25. ENGELHARDT M; WALLER C; BERTZ H; AFTING M; MERTELSMANN R; FINKE J
      HIGH-DOSE VERSUS STANDARD FILGRASTIM SIGNIFICANTLY IMPROVES MOBILIZATION OF BLOOD PROGENITORS AND FACILITATES CD34+ IMMUNOSELECTION FOR ALLOGENEIC TRANSPLANTATION

      Bone marrow transplantation
    26. VEELKEN H; LICHT T; LAIS A; KOHLER G; MERTELSMANN R; SCHAEFER HE; LUBBERT M
      DRUG-RESISTANCE OF SECONDARY ACUTE MYELOID-LEUKEMIA WITH MEGAKARYOBLASTIC FEATURES AND P190 BCR-ABL REARRANGEMENT

      Leukemia research
    27. BRUGGER W; FETSCHER S; HASSE J; FROMMHOLD H; PRESSLER K; MERTELSMANN R; ENGELHARDT R; KANZ L
      MULTIMODALITY TREATMENT INCLUDING EARLY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER

      Seminars in oncology
    28. HEIL G; KRAUTER J; BERGMANN L; HOELZER D; HOSSFELD D; MERTELSMANN R; NOENS L; SCHLIMOK G; PORT M; SCHWAB G; GANSER A
      RISK ADAPTED INDUCTION AND CONSOLIDATION THERAPY INCLUDING AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN ADULT DE-NOVO AML PATIENTS

      British Journal of Haematology
    29. WIRTH K; SCHOEPF E; MERTELSMANN R; LINDEMANN A
      LEG ULCERATION WITH ASSOCIATED THROMBOCYTOSIS - HEALING OF ULCERATIONASSOCIATED WITH TREATMENT OF THE RAISED PLATELET COUNT

      British journal of dermatology
    30. MOBEST D; MERTELSMANN R; HENSCHLER R
      SERUM-FREE EX-VIVO EXPANSION OF CD34(+) HEMATOPOIETIC PROGENITOR CELLS

      Biotechnology and bioengineering
    31. Mackensen, A; Lindemann, A; Mertelsmann, R
      Immunostimulatory cytokines in somatic cell and gene therapy

      BIOTHERAPY OF CANCERS
    32. FETSCHER S; FINKE J; ENGELHARDT R; MERTELSMANN R; LANGE W
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH 2ND PRIMARY MALIGNANCIES

      HEMATOLOGY AND CELL THERAPY
    33. GLIMM H; KIEM HP; DAROVSKY B; STORB R; WOLF J; DIEHL V; MERTELSMANN R; VONKALLE C
      EFFICIENT GENE-TRANSFER IN PRIMITIVE CD34(+) CD38(LO) HUMAN BONE-MARROW CELLS RESELECTED AFTER LONG-TERM EXPOSURE TO GALV-PSEUDOTYPED RETROVIRAL VECTOR/

      Human gene therapy
    34. MAHLKNECHT U; VONLINTIG F; MERTELSMANN R; LINDEMANN A; LUBBERT M
      SUCCESSFUL TREATMENT OF DISSEMINATED CENTRAL NERVOUS ASPERGILLOSIS INA PATIENT WITH ACUTE MYELOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    35. ENGELHARDT M; WIRTH K; MERTELSMANN R; LINDEMANN A; BRENNSCHEIDT U
      CLINICAL AND IMMUNOMODULATORY EFFECTS OF REPETITIVE 2-DAY CYCLES OF HIGH-DOSE CONTINUOUS-INFUSION IL-2

      European journal of cancer
    36. CROOCKEWIT AJ; BRONCHUD MH; AAPRO MS; BARGETZI MJ; CROWN J; GRATWOHL A; LANGE W; LUDWIG H; MARTINELLI G; MERTELSMANN R; NUESSLER V; WILLEMZE R; DEWITTE TJM; ZITTOUN R; ZWIERZINA H
      A EUROPEAN PERSPECTIVE ON HEMATOPOIETIC GROWTH-FACTORS IN HEMATOONCOLOGY - REPORT OF AN EXPERT MEETING OF THE EORTC

      European journal of cancer
    37. MACKENSEN A; VEELKEN H; LAHN M; WITTNEBEL S; BECKER D; KOHLER G; KULMBURG P; BRENNSCHEIDT U; ROSENTHAL F; FRANKE B; MERTELSMANN R; LINDEMANN A
      INDUCTION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES BY IMMUNIZATION WITH AUTOLOGOUS TUMOR-CELLS AND INTERLEUKIN-2 GENE TRANSFECTED FIBROBLASTS

      Journal of molecular medicine
    38. STINGL G; BROCKER EB; MERTELSMANN R; WOLFF K; SCHREIBER S; KAMPGEN E; SCHNEEBERGER A; TRCKA J; BRENNSCHEIDT U; VEELKEN H; BIRNSTIEL ML; ZATLOUKAL K; MAASS G; WAGNER E; BUSCHLE M; KEMPE ER; WEBER HA; VOIGT T
      PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE

      Journal of molecular medicine
    39. MERTELSMANN R; ROSENTHAL F
      GERMAN WORKING GROUP FOR GENE-THERAPY - REPORT OF THE PRESIDENT

      Journal of molecular medicine
    40. KULMBURG P; VEELKEN H; SCHMOOR C; ROSENTHAL FM; MACKENSEN A; LINDEMANN A; MERTELSMANN R
      NTS INFLUENCE ON TRANSGENE EXPRESSION FROM MONOCISTRONIC AND BICISTRONIC PLASMID VECTORS AFTER LIPOFECTION IN A HUMAN FIBROBLAST CELL-LINE

      Journal of molecular medicine
    41. FETSCHER S; FINKE J; ENGELHARDT R; MERTELSMANN R; LANGE W
      EARLY-ONSET SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Annals of hematology
    42. BURGER JA; OCHS A; WIRTH K; BERGER DP; MERTELSMANN R; ENGELHARDT R; ROESSLE M; HAAG K
      THE TRANSJUGULAR STENT IMPLANTATION FOR THE TREATMENT OF MALIGNANT PORTAL AND HEPATIC VEIN OBSTRUCTION IN CANCER-PATIENTS

      Annals of oncology
    43. DIMEO F; STIEGLITZ RD; NOVELLIFISCHER U; FETSCHER S; MERTELSMANN R; KEUL J
      CORRELATION BETWEEN PHYSICAL PERFORMANCE AND FATIGUE IN CANCER-PATIENTS

      Annals of oncology
    44. FETSCHER S; BRUGGER W; ENGELHARDT R; KANZ L; HASSE J; FROMMHOLD H; WENGER M; LANGE W; MERTELSMANN R
      DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 100 CONSECUTIVE PATIENTS WITH, LIMITED-DISEASE AND EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER

      Annals of oncology
    45. FETSCHER S; BRUGGER W; ENGELHARDT R; KANZ L; HASSE J; FROMMHOLD H; WENGER M; LANGE W; MERTELSMANN R
      DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 107 CONSECUTIVE PATIENTS WITH, LIMITED-STAGE AND EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER

      Annals of oncology
    46. MERTELSMANN R; ZENZ M
      STATE-OF-THE-ART - BALANCING SUPPORTIVE CARE WITH EMERGING CANCER THERAPIES - FULL PROCEEDINGS FROM A SATELLITE SYMPOSIUM HELD AT THE 21ST CONGRESS OF THE EUROPEAN-SOCIETY-OF-MEDICAL-ONCOLOGY (ESMO), VIENNA, AUSTRIA, 3 NOVEMBER 1996 - FOREWORD

      Annals of oncology
    47. MERTELSMANN R
      CASE-HISTORY 1 - THE USE OF EPOETIN ALFA IN DELAYED ANEMIA

      Annals of oncology
    48. MERTELSMANN R
      CASE-HISTORY 2 - THE USE OF EPOETIN ALFA BEFORE HIGH-DOSE CHEMOTHERAPY

      Annals of oncology
    49. LUBBERT M; HENSCHLER R; KREUTZ M; ANDREESEN R; MERTELSMANN R; HERRMANN F
      THE HUMAN LYSOZYME GENE UNDERGOES STEPWISE DEMETHYLATION DURING PHAGOCYTE MATURATION

      Leukemia
    50. BERTZ H; BURGER JA; KUNZMANN R; MERTELSMANN R; FINKE J
      ADOPTIVE IMMUNOTHERAPY FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) - EVIDENCE FOR A GRAFT-VERSUS-MYELOMA EFFECT

      Leukemia
    51. LUBBERT M; MERTELSMANN R; HERRMANN F
      CYTOSINE METHYLATION CHANGES DURING NORMAL HEMATOPOIESIS AND IN ACUTEMYELOID-LEUKEMIA

      Leukemia
    52. ROSENTHAL FM; MERTELSMANN R
      PRESENT STRATEGIES FOR GENE-THERAPY IN CANCER

      Onkologie
    53. KULMBURG P; RADKE M; MEZES B; MERTELSMANN R; ROSENTHAL FM
      CLONING AND SEQUENCE-ANALYSIS OF THE IMMEDIATE PROMOTER REGION AND CDNA OF PORCINE GRANULOCYTE-COLONY-STIMULATING FACTOR

      Gene
    54. FETSCHER S; BRUGGER W; BERTZ H; KRIEGER G; KANZ L; MERTELSMANN R; LANGE W
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR METASTATIC GASTRIC LEIOMYOSARCOMA

      Bone marrow transplantation
    55. ENGELHARDT M; WINKLER J; WALLER C; LANGE W; MERTELSMANN R; HENSCHLER R
      BLOOD PROGENITOR-CELL (BPC) MOBILIZATION STUDIED IN MULTIPLE-MYELOMA,SOLID TUMOR AND NON-HODGKINS-LYMPHOMA PATIENTS AFTER COMBINATION CHEMOTHERAPY AND G-CSF

      Bone marrow transplantation
    56. FETSCHER S; LUBBERT M; KANZ L; BEHRINGER D; FINKE J; MERTELSMANN R; LANGE W
      TREATMENT OF RELAPSED NON-HODGKINS-LYMPHOMA AFTER BEAM CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION BY BU CY CHEMOTHERAPY AND SALVAGE TRANSPLANTATION/

      Bone marrow transplantation
    57. BERTZ H; POTTHOFF K; MERTELSMANN R; FINKE J
      BUSULFAN CYCLOPHOSPHAMIDE IN VOLUNTEER UNRELATED DONOR (VUD) BMT - EXCELLENT FEASIBILITY AND LOW INCIDENCE OF TREATMENT-RELATED TOXICITY/

      Bone marrow transplantation
    58. POTZSCH C; FETSCHER S; MERTELSMANN R; LUBBERT M
      ACUTE MYELOMONOCYTIC LEUKEMIA SECONDARY TO SYNCHRONOUS CARCINOMAS OF THE BREAST AND LUNG, AND TO METACHRONOUS RENAL-CELL CARCINOMA

      Journal of cancer research and clinical oncology
    59. MUNDLOS S; OTTO F; MUNDLOS C; MULLIKEN JB; AYLSWORTH AS; ALBRIGHT S; LINDHOUT D; COLE WG; HENN W; KNOLL JHM; OWEN MJ; MERTELSMANN R; ZABEL BU; OLSEN BR
      MUTATIONS INVOLVING THE TRANSCRIPTION FACTOR CBFA1 CAUSE CLEIDOCRANIAL DYSPLASIA

      Cell
    60. TAMM I; GRIMME H; BERGEN E; SIMON JC; SCHOPF E; MERTELSMANN R; LINDEMANN A; BRENNSCHEIDT U
      DACARBAZINE AND INTERFERON-ALPHA FOR STAGE-IV MALIGNANT-MELANOMA

      Oncology
    61. LINDEMANN A; MERTELSMANN R
      GENE-THERAPY - A REALISTIC APPROACH TO TH E TREATMENT OF MALIGNANT DISEASES

      Der Internist
    62. VEELKEN H; MACKENSEN A; LAHN M; KOHLER G; BECKER D; FRANKE B; BRENNSCHEIDT U; KULMBURG P; ROSENTHAL FM; KELLER H; HASSE J; SCHULTZESEEMANN W; FARTHMANN EH; MERTELSMANN R; LINDEMANN A
      A PHASE-I CLINICAL-STUDY OF AUTOLOGOUS TUMOR-CELLS PLUS INTERLEUKIN-2-GENE-TRANSFECTED ALLOGENEIC FIBROBLASTS AS A VACCINE IN PATIENTS WITHCANCER

      International journal of cancer
    63. KULMBURG P; PELSTER D; MERTELSMANN R; ROSENTHAL FM
      GENE-THERAPY AND CANCER

      Geburtshilfe und Frauenheilkunde
    64. LAHN M; KOHLER G; SCHMOOR C; DENGLER W; VEELKEN H; BREENSCHEIDT U; MACKENSEN A; KULMBURG P; HENTRICH I; JESUITER H; ROSENTHAL FM; FIEBIG HH; SOMMERKAMP H; FARTHMANN EH; HASSE J; MERTELSMANN R; LINDEMANN A
      PROCESSING OF TUMOR-TISSUES FOR VACCINATION WITH AUTOLOGOUS TUMOR-CELLS

      European surgical research
    65. DIMEO FC; TILMANN MHM; BERTZ H; KANZ L; MERTELSMANN R; KEUL J
      AEROBIC EXERCISE IN THE REHABILITATION OF CANCER-PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION

      Cancer
    66. GARBE A; SPYRIDONIDIS A; MOBEST D; SCHMOOR C; MERTELSMANN R; HENSCHLER R
      TRANSFORMING-GROWTH-FACTOR-BETA-1 DELAYS FORMATION OF GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS, BUT SPARES MORE PRIMITIVE PROGENITORS DURING EX-VIVO EXPANSION OF CD34(+) HEMATOPOIETIC PROGENITOR CELLS

      British Journal of Haematology
    67. HERBST B; KOHLER G; MACKENSEN A; VEELKEN H; MERTELSMANN R; LINDEMANN A
      CD34(-BLOOD PROGENITOR-CELL AND MONOCYTE-DERIVED DENDRITIC CELLS - A COMPARATIVE-ANALYSIS() PERIPHERAL)

      British Journal of Haematology
    68. BEHRINGER D; KRESIN V; HENSCHLER R; MERTELSMANN R; LINDEMANN A
      CYTOKINE AND CHEMOKINE PRODUCTION BY CD34(- DETECTION IN SINGLE CELLS() HEMATOPOIETIC PROGENITOR CELLS )

      British Journal of Haematology
    69. DIMEO F; FETSCHER S; LANGE W; MERTELSMANN R; KEUL J
      EFFECTS OF AEROBIC EXERCISE ON THE PHYSICAL PERFORMANCE AND INCIDENCEOF TREATMENT-RELATED COMPLICATIONS AFTER HIGH-DOSE CHEMOTHERAPY

      Blood
    70. STROBEL ES; MOBEST D; VONKLEIST S; DANGEL M; RIES S; MERTELSMANN R; HENSCHLER R
      ADHESION AND MIGRATION ARE DIFFERENTIALLY REGULATED IN HEMATOPOIETIC PROGENITOR CELLS BY CYTOKINES AND EXTRACELLULAR-MATRIX

      Blood
    71. POTZSCH C; MERTELSMANN R; LUBBERT M
      CONSTITUTIONAL P53 MUTATIONS ARE INFREQUENT IN FAMILIAL AND INDIVIDUAL AGGREGATIONS OF MALIGNANT-LYMPHOMA

      Blood
    72. FETSCHER S; LUBBERT M; WALLER CF; MERTELSMANN R; LANGE W
      EARLY-ONSET OF SECONDARY CHRONIC MYELOGENOUS LEUKEMIA AFTER HIGH-DOSECHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR SMALL-CELL LUNG-CANCER

      Blood
    73. HEINZINGER M; ALI M; WALLER CF; ROSENSTIEL A; MERTELSMANN R; LANGE W
      REDUCTION OF CD34-POSITIVE CELLS WITH A TYROSINE KINASE INHIBITOR( PHILADELPHIA (PH) CHROMOSOME)

      Blood
    74. WALLER CF; HEINZINGER M; ROSENSTIEL A; WINKLER J; BURGER KJ; MERTELSMANN R; LANGE W
      TRANSPLANTATION OF PHILADELPHIA CHROMOSOME-NEGATIVE PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS IN EARLY CHRONIC PHASE CML AFTER MOBILIZATION WITH ICE-CHEMOTHERAPY FOLLOWED BY SIMULTANEOUS ADMINISTRATION OF RHIL-3 AND RHG-CSF OR OF RHC-CSF ALONE

      Blood
    75. GLIMM H; KLINGENBERG S; FLUGGE K; HOFMANN VM; LANGE W; MERTELSMANN R; VONKALLE C
      EFFICIENT GENE-TRANSFER INTO HUMAN PRIMITIVE HEMATOPOIETIC PROGENITORCELLS BY A PHARMACEUTICAL GRADE SERUM-FREE RETROVIRAL VECTOR MEDIUM AND ITS LARGE-SCALE GMP-PRODUCTION

      Blood
    76. FINKE J; BERTZ H; KUNZMANN R; BEHRINGER D; AFTING M; HEIDECKER E; LANG H; POTTHOFF K; WASCH R; MERTELSMANN R
      ALLOGENEIC TRANSPLANTATION FROM UNRELATED DONORS - IMPROVED OUTCOME USING IN-VIVO T-CELL DEPLETION

      Blood
    77. ENGELHARDT M; LANGE W; HENSCHLER R; MOORE MAS; MERTELSMANN R
      EFFECT OF PROLONGED MYELOSUPPRESSIVE CHEMOTHERAPY TREATMENT ON APHERESIS RESULTS AND TELOMERE LENGTH

      Blood
    78. SPYRIDONIDIS A; BERNHARDT W; BEHRINGER D; MERTELSMANN R; HENSCHLER R
      A CULTURE STEP SUBSTANTIALLY ENHANCES THE DETECTION OF OCCULT TUMOR-CELLS IN BONE-MARROW OF BREAST-CANCER PATIENTS

      Blood
    79. PASSWEG JR; FASSAS A; BLACK CM; FINKE J; JOUET JP; LOCATELLI F; MARMONT A; MARTINI A; MERTELSMANN R; PETER HH; PRENTICE HG; GRATWOHL A; TYNDALL A
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASE - A PRELIMINARY-REPORT

      Blood
    80. MOBEST D; JUNGHAHN I; FICHTNER I; BECKER M; JUST U; MERTELSMANN R; GOAN S; HENSCHLER R
      KINETICS OF NOD SCID MOUSE-REPOPULATING CELLS (SRC) DIVERGE FROM COLONY-FORMING CELLS (CFC) AND LONG-TERM CULTURE-INITIATING CELLS (LTC-IC)DURING EX-VIVO EXPANSION OF CD34+ BLOOD PROGENITOR CELLS (BPC)/

      Blood
    81. FETSCHER S; TECHNAU K; MERTENS R; FINKE J; MERTELSMANN R; LANGE W
      INCIDENCE AND MORBIDITY OF HERPES-ZOSTER INFECTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Blood
    82. GOAN S; JUNGHAHN I; FICHTNER I; BECKER M; JUST U; MARTINYBARON G; MERTELSMANN R; HENSCHLER R
      A BONE-MARROW STROMA-FORMING POTENTIAL OF HUMAN BLOOD IS DETECTABLE THROUGH THE HUMANIZED NOD SCID-MOUSE/

      Blood
    83. SPYRIDONIDIS A; BERNHARDT W; BEHRINGER D; PFLUG A; MERTELSMANN R; HENSCHLER R
      PROLIFERATION AND SURVIVAL OF MAMMARY-CARCINOMA CELLS ARE INFLUENCED BY CULTURE CONDITIONS USED FOR EX VIVO-EXPANSION OF CD34+ BLOOD PROGENITOR CELLS

      Blood
    84. HEIL G; KRAUTER J; RAGHAVACHAR A; HOELZER D; HOSSFELD D; MERTELSMANN R; NOENS L; SCHLIMOK G; PORT M; SCHWAB G; GANSER A
      RISK ADAPTED INDUCTION AND CONSOLIDATION THERAPY INCLUDING AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN ADULT DE-NOVO AML PATIENTS

      Blood
    85. VEELKEN K; OSTERROTH F; LINDEMANN A; MERTELSMANN R
      RAPID EXPRESSION CLONING OF B-CELL LYMPHOMA-DERIVED IMMUNOGLOBULIN GENES FOR ANTIIDIOTYPIC VACCINATION AND FUNCTIONAL ANALYSES OF FAB-FRAGMENTS

      Blood
    86. ALBRECHT B; KOHLER G; MERTELSMANN R; FISCH P
      TRANSDUCTION OF HUMAN DENDRITIC CELLS WITH RECOMBINANT SEMLIKI-FOREST-VIRUS CODING FOR THE OVARIAN-CARCINOMA ASSOCIATED ANTIGEN ALPHA-FOLATE RECEPTOR FOR THE GENERATION OF CYTOTOXIC T-CELLS FROM CANCER-PATIENTS

      Blood
    87. STOCKSCHLADER M; HAISS M; EXNER S; FEHSE B; SCHADE U; ZANDER A; RUGER R; KOCH S; ROSENTHAL F; VONKALLE C; MERTELSMANN R; FINKE J
      FIBRONECTIN ENHANCES RETROVIRAL TRANSDUCTION OF PRIMARY HUMAN T-LYMPHOCYTES

      Blood
    88. GLIMM H; KEIM HP; DAROVSKY B; STORB R; WOLF J; MERTELSMANN R; VONKALLE C
      RETROVIRAL GENE-TRANSFER IN RESELECTED CD34(+) CD38(LO) AND CD34(+)/CD38(HL) HUMAN HEMATOPOIETIC PROGENITOR CELLS/

      Blood
    89. LUBBERT M; HAAK HL; KUNZMANN R; DANZERDRIESSEN S; VERHOEF G; MERTELSMANN R; WIJERMANS P
      CYTOGENETIC RESPONSE TO LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE (DAC) IN POOR-RISK MYELODYSPLASTIC SYNDROMES (MDS) - PHASE-II STUDY RESULTS

      Blood
    90. LICHT T; LUBBERT M; MARTENS C; BROSS KJ; FIEBIG HH; MERTELSMANN R; HERRMANN F
      MODULATION OF VINDESINE AND DOXORUBICIN RESISTANCE IN MULTIDRUG-RESISTANT PLEURAL MESOTHELIOMA CELLS BY TUMOR-NECROSIS-FACTOR-ALPHA (VOL 1,PG 123, 1995)

      Cytokines cellular & molecular therapy
    91. LANGE W; MERTELSMANN R
      BLOOD STEM-CELL TRANSPLANTATION - CURRENT STATE AND PERSPECTIVES

      Deutsche Medizinische Wochenschrift
    92. LINDEMANN A; MERTELSMANN R
      MOLECULAR MEDICINE - FROM GENE TO TREATME NT

      Deutsche Medizinische Wochenschrift
    93. STINGL G; BROCKER EB; MERTELSMANN R; WOLFF K; SCHREIBER S; KAMPGEN E; SCHNEEBERGER A; DUMMER W; BRENNSCHEID U; VEELKEN H; BIRNSTIEL ML; ZATLOUKAL K; SCHMIDT W; MAASS G; WAGNER E; BUSCHLE M; GIESE M; KEMPE ER; WEBER HA; VOIGT T
      PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE

      Human gene therapy
    94. ROSENTHAL FM; KULMBURG P; FRUH R; PFEIFER C; VEELKEN H; MACKENSEN A; KOHLER G; LINDEMANN A; MERTELSMANN R
      SYSTEMIC HEMATOLOGICAL EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR PRODUCED BY IRRADIATED GENE-TRANSFECTED FIBROBLASTS

      Human gene therapy
    95. VEELKEN H; RE D; KULMBURG P; ROSENTHAL FM; MACKENSEN A; MERTELSMANN R; LINDEMANN A
      SYSTEMATIC EVALUATION OF CHIMERIC MARKER GENES ON DICISTRONIC TRANSCRIPTION UNITS FOR REGULATED EXPRESSION OF TRANSGENES IN-VITRO AND IN-VIVO

      Human gene therapy
    96. OTTO F; SCHMID P; MACKENSEN A; WEHR U; SEIZ A; BRAUN M; GALANOS C; MERTELSMANN R; ENGELHARDT R
      PHASE-II TRIAL OF INTRAVENOUS ENDOTOXIN IN PATIENTS WITH COLORECTAL AND NONSMALL CELL LUNG-CANCER

      European journal of cancer
    97. FETSCHER S; KIANI A; KANZ L; BRUGGER W; LANGE W; MERTELSMANN R
      NEOADJUVANT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR INOPERABLE RELAPSE OF NUCHAL LIPOSARCOMA RESISTANT TO STANDARD-DOSE CHEMOTHERAPY

      Annals of oncology
    98. WEBERNORDT RM; EGEN C; WEHINGER J; MERTELSMANN R; FINKE J
      CONSTITUTIVE ACTIVATION OF STAT PROTEINS IN PRIMARY HUMAN LEUKEMIA-CELLS

      The FASEB journal
    99. VEELKEN H; KOHLER G; SCHNEIDER J; DIERBACH H; MERTELSMANN R; SCHAEFER HE; LUBBERT M
      HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA LYMPHOMA IN 2 PATIENTS FROM BUCHAREST, ROMANIA/

      Leukemia
    100. LANGE W; HENSCHLER R; MERTELSMANN R
      BIOLOGICAL AND CLINICAL ADVANCES IN STEM-CELL EXPANSION

      Leukemia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 23:40:50